Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 344

1.

Dicer Sequencing, Whole Genome Methylation Profiling, mRNA and smallRNA Sequencing Analysis in Basal Cell Carcinoma.

Sand M, Bromba A, Sand D, Gambichler T, Hessam S, Becker JC, Stockfleth E, Meyer T, Bechara FG.

Cell Physiol Biochem. 2019;53(5):760-773. doi: 10.33594/000000171.

2.

Hypereosinophilic syndrome complicated by severe vascular damage and gangrene.

Gambichler T, Kröger ES, Tannapfel A, Dörler M, Susok L.

J Vasc Surg Cases Innov Tech. 2019 Aug 28;5(3):384-387. doi: 10.1016/j.jvscit.2017.12.001. eCollection 2019 Sep.

3.

Disseminated Emergomycosis in a Person with HIV Infection, Uganda.

Rooms I, Mugisha P, Gambichler T, Hadaschik E, Esser S, Rath PM, Haase G, Wilmes D, McCormick-Smith I, Rickerts V.

Emerg Infect Dis. 2019 Sep;25(9):1750-1751. doi: 10.3201/eid2509.181234.

4.

Haemorrhagic bullous lesions in cutaneous light-chain amyloidosis with smouldering myeloma.

Gambichler T, Doerler M, Nöpel-Dünnebacke S, Matschke J, Bräsen JH, Linke RP, Susok L.

J Eur Acad Dermatol Venereol. 2019 Aug 7. doi: 10.1111/jdv.15844. [Epub ahead of print] No abstract available.

PMID:
31390676
5.

Decline of PD-1 positive circulating T regulatory cells predicting more favorable clinical outcome of melanoma patients under immune checkpoint blockade.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC.

Br J Dermatol. 2019 Jul 30. doi: 10.1111/bjd.18379. [Epub ahead of print]

PMID:
31361026
6.

Autoimmune radiculoplexus neuropathy under adjuvant nivolumab treatment of a female patient with melanoma.

Gambichler T, Susok L, Fels M, Schneider-Gold C, Hofzum Berge F, Stockfleth E, Ayzenberg I.

Br J Dermatol. 2019 Jul 19. doi: 10.1111/bjd.18358. [Epub ahead of print] No abstract available.

PMID:
31325163
7.

MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma.

Fan K, Gravemeyer J, Ritter C, Rasheed K, Gambichler T, Moens U, Shuda M, Schrama D, Becker JC.

J Invest Dermatol. 2019 Jul 5. pii: S0022-202X(19)31853-6. doi: 10.1016/j.jid.2019.06.135. [Epub ahead of print]

PMID:
31283928
8.

Expression of indolamine-2,3-dioxygenase and cyclooxygenase-2 in different disease stages of cutaneous squamous cell carcinoma.

Gambichler T, Selke L, Rüddel I, Dreißigacker M, Stockfleth E, Schmitz L.

J Eur Acad Dermatol Venereol. 2019 Jun 28. doi: 10.1111/jdv.15763. [Epub ahead of print] No abstract available.

PMID:
31251418
9.

Morphologic and immunophenotypical features distinguishing Merkel cell polyomavirus-positive and negative Merkel cell carcinoma.

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Herfs M, Touzé A, Samimi M, Guyétant S.

Mod Pathol. 2019 Nov;32(11):1605-1616. doi: 10.1038/s41379-019-0288-7. Epub 2019 Jun 14.

PMID:
31201352
10.

A Brief Communication on Circulating PD-1-positive T-Regulatory Lymphocytes in Melanoma Patients Undergoing Adjuvant Immunotherapy With Nivolumab.

Gambichler T, Schröter U, Höxtermann S, Susok L, Stockfleth E, Becker JC.

J Immunother. 2019 Sep;42(7):265-268. doi: 10.1097/CJI.0000000000000277.

PMID:
31145230
11.

S2k-Leitlinie Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) - Update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C.

J Dtsch Dermatol Ges. 2019 May;17(5):562-577. doi: 10.1111/ddg.13841_g.

PMID:
31115985
12.

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) - update 2018.

Becker JC, Eigentler T, Frerich B, Gambichler T, Grabbe S, Höller U, Klumpp B, Loquai C, Krause-Bergmann A, Müller-Richter U, Pföhler C, Schneider-Burrus S, Stang A, Terheyden P, Ugurel S, Veith J, Mauch C.

J Dtsch Dermatol Ges. 2019 May;17(5):562-576. doi: 10.1111/ddg.13841. Epub 2019 May 6.

PMID:
31056838
13.

Low Drosha protein expression in cutaneous T-cell lymphoma is associated with worse disease outcome.

Gambichler T, Salveridou K, Schmitz L, Käfferlein HU, Brüning T, Stockfleth E, Sand M, Lang K.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1695-1699. doi: 10.1111/jdv.15652. Epub 2019 Jun 6.

PMID:
31055868
14.

Somatic mutations in kinetochore gene KNSTRN are associated with basal proliferating actinic keratoses and cutaneous squamous cell carcinoma.

Schmitz L, Grinblat B, Novak B, Hoeh AK, Händschke K, von Dobbeler C, Bierhoff E, Szeimies RM, Gambichler T, Torezan L, Festa-Neto C, Stockfleth E, Dirschka T.

J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1535-1540. doi: 10.1111/jdv.15615. Epub 2019 May 8.

PMID:
30972880
15.

Evaluation of two histological classifications for actinic keratoses - PRO classification scored highest inter-rater reliability.

Schmitz L, Gupta G, Stücker M, Doerler M, Gambichler T, Welzel J, Szeimies RM, Bierhoff E, Stockfleth E, Dirschka T.

J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1092-1097. doi: 10.1111/jdv.15580. Epub 2019 Apr 3.

PMID:
30887613
16.

Disseminated skin necroses in a patient with multiple myeloma and monoclonal cryoglobulinaemia.

Gambichler T, Schug T, Doerler M.

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e166-e167. doi: 10.1111/jdv.15403. Epub 2019 Feb 27. No abstract available.

PMID:
30811662
17.

Decreased 5-hydroxymethylcytosine immunoreactivity in primary Merkel cell carcinoma is a strong predictor for disease-specific death.

Gambichler T, Schmitt K, Rüddel I, Dreibigacker M, Stockfleth E, Becker JC.

Br J Dermatol. 2019 Aug;181(2):389-390. doi: 10.1111/bjd.17705. Epub 2019 Apr 23. No abstract available.

PMID:
30703276
18.

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.

Gambichler T, Stockfleth E, Susok L.

J Immunother Cancer. 2018 Oct 30;6(1):113. doi: 10.1186/s40425-018-0430-y.

19.

Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas.

Kervarrec T, Tallet A, Miquelestorena-Standley E, Houben R, Schrama D, Gambichler T, Berthon P, Le Corre Y, Hainaut-Wierzbicka E, Aubin F, Bens G, Tabareau-Delalande F, Beneton N, Fromont G, Arbion F, Leteurtre E, Touzé A, Samimi M, Guyétant S.

Mod Pathol. 2019 Apr;32(4):499-510. doi: 10.1038/s41379-018-0155-y. Epub 2018 Oct 22.

PMID:
30349028
20.

Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.

Hessam S, Gambichler T, Skrygan M, Sand M, Rüddel I, Scholl L, Bechara FG.

Eur J Dermatol. 2018 Aug 1;28(4):449-456. doi: 10.1684/ejd.2018.3369.

PMID:
30325321
21.

Die histologische intraläsionale Heterogenität aktinischer Keratosen als Zeichen von Feldkanzerisierung.

Schmitz L, Stücker M, Gambichler T, Stockfleth E, Dirschka T.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1211-1218. doi: 10.1111/ddg.13658_g. No abstract available.

PMID:
30300486
22.

Melanocytic soluble adenylyl cyclase protein expression around lentigo maligna and in contralateral control skin.

Gambichler T, Doerler M, Kempka J, Bechara FG, Stücker M.

Clin Exp Dermatol. 2019 Apr;44(3):300-303. doi: 10.1111/ced.13754. Epub 2018 Sep 27.

PMID:
30264463
23.

Histological intralesional heterogeneity of actinic keratoses relates to field cancerization.

Schmitz L, Stücker M, Gambichler T, Stockfleth E, Dirschka T.

J Dtsch Dermatol Ges. 2018 Oct;16(10):1211-1217. doi: 10.1111/ddg.13658. Epub 2018 Sep 24.

PMID:
30248236
24.

Ultraviolet A1 Phototherapy for Fibrosing Conditions.

Gambichler T, Schmitz L.

Front Med (Lausanne). 2018 Aug 27;5:237. doi: 10.3389/fmed.2018.00237. eCollection 2018. Review.

25.

Argon plasma coagulation of actinic keratoses imaged by optical coherence tomography: An in vivo study indicating a possible lesion-directed treatment.

Schmitz L, Hessam S, Scholl L, Reitenbach S, Segert MH, Gambichler T, Stockfleth E, Bechara FG.

J Biophotonics. 2018 Oct;11(10):e201800075. doi: 10.1002/jbio.201800075. Epub 2018 Jul 9.

PMID:
29893051
26.

Lysyl oxidase-like-2 mutations and reduced mRNA and protein expression in mid-dermal elastolysis.

Gambichler T, Mahjurian-Namari M, Reininghaus L, Schmitz L, Skrygan M, Schulze HJ, Schaller J, Girolomoni G.

Clin Exp Dermatol. 2019 Jan;44(1):47-51. doi: 10.1111/ced.13652. Epub 2018 May 29.

PMID:
29845638
27.

Absence of immunoglobulin heavy chain rearrangement in primary Merkel cell carcinomas.

Gambichler T, Segert MH, Höxtermann S, Stockfleth E, Doerler M.

Clin Exp Dermatol. 2018 Dec;43(8):947. doi: 10.1111/ced.13629. Epub 2018 May 24. No abstract available.

PMID:
29797735
28.

Response: field cancerization and koebnerized skin tumours.

Gambichler T, Schmitz L.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e4-e5. doi: 10.1111/jdv.15086. Epub 2018 Jun 7. No abstract available.

PMID:
29797674
29.

Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.

Schmitz L, Gupta G, Segert MH, Kost R, Sternberg J, Gambichler T, Stockfleth E, Dirschka T.

Skin Pharmacol Physiol. 2018;31(4):206-211. doi: 10.1159/000488248. Epub 2018 May 23.

PMID:
29791916
30.

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.

D'Angelo SP, Russell J, Lebbé C, Chmielowski B, Gambichler T, Grob JJ, Kiecker F, Rabinowits G, Terheyden P, Zwiener I, Bajars M, Hennessy M, Kaufman HL.

JAMA Oncol. 2018 Sep 1;4(9):e180077. doi: 10.1001/jamaoncol.2018.0077. Epub 2018 Sep 13.

31.

Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.

Schmitz L, Gambichler T, Kost C, Gupta G, Stücker M, Stockfleth E, Dirschka T.

Br J Dermatol. 2019 Apr;180(4):916-921. doi: 10.1111/bjd.16536. Epub 2018 Jun 29.

PMID:
29526028
32.

Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery.

Gambichler T, Rüddel I, Hessam S, Bechara FG, Stockfleth E, Schmitz L.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1485-1491. doi: 10.1111/jdv.14887. Epub 2018 Mar 13.

PMID:
29478287
33.

Histological findings after argon plasma coagulation: an ex-vivo study revealing a possible role in superficial ablative treatment of the skin.

Schmitz L, Hessam S, Scholl L, Reitenbach S, Segert MH, Gambichler T, Stockfleth E, Bechara FG.

Arch Dermatol Res. 2018 Mar;310(2):157-163. doi: 10.1007/s00403-018-1810-3. Epub 2018 Jan 19.

PMID:
29350263
34.

Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.

Schmitz L, Gambichler T, Gupta G, Stücker M, Dirschka T.

J Eur Acad Dermatol Venereol. 2018 May;32(5):752-756. doi: 10.1111/jdv.14682. Epub 2017 Dec 18.

PMID:
29117441
35.

Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI).

Schmitz L, von Dobbeler C, Gupta G, Gambichler T, Szeimies RM, Morton CA, Dirschka T.

Photodiagnosis Photodyn Ther. 2018 Mar;21:66-70. doi: 10.1016/j.pdpdt.2017.10.007. Epub 2017 Oct 16.

PMID:
29051122
36.

Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single-centre analysis.

Gambichler T, Brown V, Steuke AK, Schmitz L, Stockfleth E, Susok L.

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):972-977. doi: 10.1111/jdv.14629. Epub 2017 Nov 22.

PMID:
29024038
37.

Irradiance, as well as body site and timing of readings, is important in determining ultraviolet A minimal erythemal dose: reply from the authors.

Gambichler T, Wolf P.

Br J Dermatol. 2018 Jan;178(1):298-299. doi: 10.1111/bjd.16044. Epub 2017 Dec 1. No abstract available.

PMID:
28990167
38.

Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.

Hessam S, Sand M, Gambichler T, Skrygan M, Rüddel I, Bechara FG.

Br J Dermatol. 2018 Mar;178(3):761-767. doi: 10.1111/bjd.16019. Epub 2018 Jan 31.

PMID:
28975626
39.

Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers.

Gambichler T, Kulik MA, Skrygan M, Rooms I, Höxtermann S.

Postepy Dermatol Alergol. 2017 Aug;34(4):299-305. doi: 10.5114/ada.2017.69307. Epub 2017 Aug 1.

40.

Actinic keratoses show variable histological basal growth patterns - a proposed classification adjustment.

Schmitz L, Gambichler T, Gupta G, Stücker M, Stockfleth E, Szeimies RM, Dirschka T.

J Eur Acad Dermatol Venereol. 2018 May;32(5):745-751. doi: 10.1111/jdv.14512. Epub 2017 Oct 16.

PMID:
28796914
41.

Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background.

Hessam S, Sand M, Lang K, Käfferlein HU, Scholl L, Gambichler T, Skrygan M, Brüning T, Stockfleth E, Bechara FG.

Dermatology. 2017;233(2-3):129-135. doi: 10.1159/000478043. Epub 2017 Jul 28.

42.

T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid.

Gambichler T, Tsitlakidon A, Skrygan M, Höxtermann S, Susok L, Hessam S.

Clin Exp Dermatol. 2017 Aug;42(6):632-637. doi: 10.1111/ced.13135. Epub 2017 Jun 7.

PMID:
28590036
43.

Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma.

Gambichler T, Gnielka M, Rüddel I, Stockfleth E, Stücker M, Schmitz L.

Cancer Immunol Immunother. 2017 Sep;66(9):1199-1204. doi: 10.1007/s00262-017-2015-x. Epub 2017 May 13.

PMID:
28501937
44.

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.

Gambichler T, Strutzmann S, Tannapfel A, Susok L.

BMC Cancer. 2017 May 12;17(1):327. doi: 10.1186/s12885-017-3313-6.

45.

Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.

Sand M, Hessam S, Amur S, Skrygan M, Bromba M, Stockfleth E, Gambichler T, Bechara FG.

J Dermatol Sci. 2017 May;86(2):142-148. doi: 10.1016/j.jdermsci.2017.01.012. Epub 2017 Jan 31.

PMID:
28187958
46.

Diffuse angiomatosis with severe facial disfigurement.

Gambichler T, Ziarna S, Deutsch A, Janus A, Stücker M, Doerler M.

Clin Exp Dermatol. 2017 Mar;42(2):208-210. doi: 10.1111/ced.13011. Epub 2017 Jan 4. No abstract available.

PMID:
28052359
47.

Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.

Hessam S, Sand M, Skrygan M, Gambichler T, Bechara FG.

Inflammation. 2017 Apr;40(2):464-472. doi: 10.1007/s10753-016-0492-2.

PMID:
28028756
48.

Determination of the minimal erythema dose for ultraviolet A1 radiation.

Gambichler T, Majert J, Pljakic A, Rooms I, Wolf P.

Br J Dermatol. 2017 Jul;177(1):238-244. doi: 10.1111/bjd.15245. Epub 2017 Jun 8.

PMID:
27995628
49.

Expression of PIWIL3 in primary and metastatic melanoma.

Gambichler T, Kohsik C, Höh AK, Lang K, Käfferlein HU, Brüning T, Stockfleth E, Stücker M, Dreißigacker M, Sand M.

J Cancer Res Clin Oncol. 2017 Mar;143(3):433-437. doi: 10.1007/s00432-016-2305-2. Epub 2016 Nov 17.

PMID:
27858163
50.

Left-sided laterality of Merkel cell carcinoma in a German population: more than just sun exposure.

Gambichler T, Wieland U, Silling S, Dreißigacker M, Schaller J, Schulze HJ, Oellig F, Kreuter A, Stücker M, Bechara FG, Stockfleth E, Becker JC.

J Cancer Res Clin Oncol. 2017 Feb;143(2):347-350. doi: 10.1007/s00432-016-2293-2. Epub 2016 Oct 24.

PMID:
27778198

Supplemental Content

Loading ...
Support Center